Arkansas recalls
3,351 federal recalls affecting Arkansas in the last 12 months - 140 Arkansas-specific plus 3,211 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-04-22FDA-DeviceIntegra LifeSciencesClass IINationwideStop using Integra Cytal Wound Matrix
Integra LifeSciences' Cytal Wound Matrix 2-Layer 5x5 cm wound dressing (Product ID: WSM0505) has been recalled because some units have higher-than-safe levels of endotoxin, a bacterial substance that can trigger immune reactions. The affected product was distributed nationwide, and no injuries have been reported so far.
- 2026-04-22FDA-Device3B MedicalClass IINationwideCheck your React Health PHOENIX 5L concentrator
3B Medical distributed 2 units of the React Health PHOENIX 5L Oxygen Concentrator that did not meet the company's internal quality standards. The devices were distributed in New York. No injuries have been reported.
- 2026-04-22FDA-DeviceSiemensClass IINationwideContact Siemens about ARTIS Pheno imaging system
Siemens has recalled certain ARTIS Pheno VE30A and VE40A imaging systems used in hospitals and medical facilities. During 3D imaging procedures, these systems may produce images with uneven brightness, potentially leading to less accurate reconstructions and unintended low-dose radiation exposure to patients.
- 2026-04-22FDA-DeviceWilson-CookClass IINationwideStop using Wilson-Cook Instinct Plus clipping devices
Wilson-Cook Medical is recalling Instinct Plus Endoscopic Clipping Devices (model G58010) due to increased complaints about potential device malfunction during use. The recall affects units manufactured between September 2, 2023 and April 20, 2025 and distributed worldwide. No injuries have been reported.
- 2026-04-22FDA-DeviceArjohuntleighClass IINationwideStop using Arjo Tenor patient lift models KHA1000, KHA1010
Certain Arjo Tenor mobile patient lifts contain actuators with an internal component that may not be strong enough to safely hold the load. In the worst case, this could cause the lifting arm to suddenly drop uncontrolled. This affects 119 units with specific serial numbers manufactured in certain batches.
- 2026-04-22FDA-DeviceLinkbioClass IINationwideCheck your LinkBio CORE Workstation Planning Date
The LinkBio CORE Workstation, part of the CORE Shoulder System, may show an incorrect Planning Date when you view cases in the Start Case menu. This could lead to confusion about case timing. Five units are affected across Alabama, Florida, and Kansas.
- 2026-04-22FDA-DeviceBeta BionicsClass IINationwideUpdate your Beta Bionics iLet Ace Pump immediately
Certain versions of the iLet Ace Pump software (1.3.7, 1.4.2, and 1.4.3) have a security flaw that allows someone to bypass the Lock Screen and Limited Access Passcode Screen by pressing icons in the status bar. This could let an unauthorized person make false meal announcements or stop insulin delivery, risking severe low blood sugar.
- 2026-04-22FDA-DeviceRemelClass IINationwideCheck Remel Yeastone Broth test results
Remel's Yeastone Broth (11ML, 10/BOX, model YY3462) may give wrong results when labs use it to test how fungi respond to antifungal medicines. If a lab doesn't catch the bad result during its own quality checks, doctors might delay treatment or switch to a different antifungal drug unnecessarily.
- 2026-04-22FDA-DevicePhilipsClass IINationwideContact Philips about AneurysmFlow software update
Philips AneurysmFlow is software used by doctors to help evaluate aneurysm treatment with flow diverter stents. The software's Mean Aneurysm Flow Amplitude (MAFA) ratio does not reliably predict whether the aneurysm is successfully closed, but doctors may be using it to make treatment decisions based on the user manual.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B Braun hemodialysis bloodlines Model B3-4630M4705
B Braun Medical Inc is recalling specific hemodialysis bloodline tubing (Model B3-4630M4705) because small air bubbles can accumulate in the arterial line when blood gases stick to the tubing under negative pressure. This could affect dialysis treatment safety. The recall affects units manufactured since August 5, 2025.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B. Braun hemodialysis bloodlines model B3-3632M3705
B. Braun Medical Inc is recalling specific hemodialysis bloodline tubing because small air bubbles can accumulate in the arterial line during dialysis treatment. This happens when blood gases stick to the tubing when negative pressure is applied. The affected units were manufactured on or after August 1, 2025.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B. Braun StreamLine Bloodline tubing
B. Braun Medical Inc is recalling certain hemodialysis bloodlines (model SL-2000M2095L) because small air bubbles can collect in the arterial line when the tubing is under negative pressure. This happens because blood gases stick to the inside of the tubing. No injuries have been reported.
- 2026-04-22FDA-DeviceB. BraunClass INationwideB. Braun Hemodialysis Bloodlines, STREAMLINE FRESENIUS FOR DAVITA. Model Number: SL-2000M2095DA.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
- 2026-04-22FDA-DeviceB. BraunClass INationwideB. Braun Hemodialysis Bloodlines, STREAMLINE BLOODLINE SET FOR DIALOG. Model Number: SL-2010M2096
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B. Braun STREAMLINE BLOODLINE SET
B. Braun Medical Inc is recalling STREAMLINE BLOODLINE SET FOR DIALOG DR. (Model SL-2010M2096A) due to a potential risk of small air bubbles accumulating in the arterial line during hemodialysis treatment. This happens when blood gases stick to the tubing under negative pressure, which could affect treatment safety. The recall affects units manufactured on or after June 9, 2025.
- 2026-04-22FDA-DeviceInsuletClass INationwideStop using affected Omnipod 5 Pods immediately
Certain Omnipod 5 Pods from 49 specific manufacturing lots contain an internal tear in the soft cannula. This defect causes insulin to leak inside the Pod instead of being delivered to your body. In some cases, the Pod may shut down completely and stop delivering insulin, or deliver less insulin than needed.
- 2026-04-22FDA-DrugAvantorClass IIINationwideStop using Avantor Magnesium Chloride
Avantor Performance Materials has recalled Magnesium Chloride, 6-Hydrate Crystal (500G bottles, Lot 23G3161005, expiration 9/21/2027) because the product does not meet strength specifications. This bulk pharmaceutical ingredient may be less potent than labeled.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IINationwideStop using Skin Script Blemish Spot Treatment
Island Kinetics, Inc. (d.b.a. CoValence Laboratories) is recalling specific lots of Skin Script Blemish Spot Treatment because the product failed stability testing. This means the product may not maintain its intended strength or safety over time. No injuries have been reported.
- 2026-04-22FDA-DrugThe Harvard DrugClass IINationwideStop using recalled memantine hydrochloride capsules
Major Pharmaceuticals is recalling memantine hydrochloride extended-release 7 mg capsules (lot N02425, expiring 05/31/2027) because the capsules may not dissolve properly in the body. This means the medication may not work as intended. The affected capsules were distributed nationwide.
- 2026-04-22FDA-DrugInternational Medication SystemsClass IINationwideStop using recalled epinephrine injection
International Medication Systems Ltd. is recalling one lot of epinephrine injection due to concerns that the sterility of the product cannot be assured. The affected lot (EA038A5, expiring 08/2026) was distributed nationwide. No injuries have been reported.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IIINationwideStop using Island Kinetics Essential Calming Skin Gel
Island Kinetics' Essential Calming Skin Gel containing hydrocortisone 1% may contain less active ingredient than labeled. This affects lot 4212D4 with an expiration date of 07/31/2026. The product was distributed nationwide.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IIINationwideStop using Island Kinetics Hydrocortisone Balm
Island Kinetics' Skin Rehab Calming Skin Gel with Hydrocortisone 1% (Lot 4212D2, expires 07/03/2026) does not contain the correct amount of active ingredient. The product is weaker than labeled and may not work as intended for skin inflammation or itching.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IIINationwideStop using Remedy Gel hydrocortisone
Remedy Gel, a hydrocortisone 1% topical treatment distributed by glo Skin Beauty, contains less active ingredient than labeled. Affected bottles (lots 4155D2 and 4155D3, expiring 05/15/2026) may not provide the expected therapeutic effect. No injuries have been reported.
- 2026-04-22FDA-DrugNephronClass IINationwideStop using Nephron SC albuterol solution
Nephron SC is recalling albuterol sulfate inhalation solution (0.5%, 30x5 mL vials, Lot AB6001, expiring 1/15/2027) because the labels are illegible and cannot be read clearly. This makes it difficult to verify the correct dose and medication details. The recall affects 146,280 vials distributed nationwide.
- 2026-04-22FDA-DrugSun PharmaceuticalClass IINationwideStop using Taro fluocinonide cream
Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to viscosity testing that showed the cream is thicker than the approved specification. This may affect how the medication spreads and absorbs. No injuries have been reported.
- 2026-04-22FDA-DrugSun PharmaceuticalClass IINationwideStop using Taro Fluocinonide Cream, Lot AD76251
Taro Pharmaceuticals is recalling Fluocinonide 0.05% Cream (30g tubes, Lot AD76251, expiring 6/30/2026) because the product's thickness is outside the acceptable range. This was discovered during stability testing. The thicker-than-normal cream may affect how well it spreads and works on skin.
- 2026-04-22FDA-DrugSun PharmaceuticalClass IINationwideStop using Taro fluocinonide cream
Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to a manufacturing defect. Testing found the cream's thickness was thicker than specifications allow, which could affect how the medication works on your skin.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
The FDA inspected the manufacturing facility for QC Quality Choice menthol cough drops on August 15, 2025, and found observations that may affect product quality. The company is recalling one lot of vanilla honey flavor cough drops sold nationwide.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
QC Quality Choice menthol cough drops are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects specific lot numbers with expiration dates in May and July 2026. No injuries have been reported.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
QC Quality Choice Menthol-Cough Suppressant Oral Anesthetic Cough Drops in Honey Lemon flavor are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility in August 2025. The affected product is the 30-count bag with lot number 20240720 and expiration date 07/20/2026.
Get notified about new Arkansas recalls
Free weekly digest. Add Arkansas to your profile to filter alerts to your state.
Get the Sunday Brief